ROLE OF DEPOT NEUROLEPTICS IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS

被引:15
|
作者
LEVINE, J [1 ]
SCHOOLER, NR [1 ]
CASSANO, GB [1 ]
机构
[1] UNIV PISA, INST CLIN PSYCHIAT, I-56100 PISA, ITALY
关键词
D O I
10.1017/S0033291700030907
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:383 / 386
页数:4
相关论文
共 50 条
  • [21] AN OPEN TRIAL OF BUSPIRONE ADDED TO NEUROLEPTICS IN SCHIZOPHRENIC-PATIENTS
    GOFF, DC
    MIDHA, KK
    BROTMAN, AW
    MCCORMICK, S
    WAITES, M
    AMICO, ET
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1991, 11 (03) : 193 - 197
  • [22] CERTAIN NEUROLEPTICS REDUCE BONE MINERALIZATION IN SCHIZOPHRENIC-PATIENTS
    HIGUCHI, T
    KOMODA, T
    SUGISHITA, M
    YAMAZAKI, J
    MIURA, M
    SAKAGISHI, Y
    YAMAUCHI, T
    NEUROPSYCHOBIOLOGY, 1987, 18 (04) : 185 - 188
  • [23] INFLUENCE OF MODITEN-DEPOT TREATMENT ON DURATION AND QUALITY OF REMISSIONS IN SCHIZOPHRENIC-PATIENTS
    VOVIN, RY
    GUROVICH, IY
    ERYSHEV, OF
    ZAITSEV, SG
    MAGALIF, AY
    NIKITINA, GF
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1977, 77 (05): : 743 - 749
  • [24] THE PROGNOSTIC VALUE OF THE EARLY RESPONSE OF SCHIZOPHRENIC-PATIENTS TO NEUROLEPTICS CONCERNING THE FOLLOWING COURSE OF TREATMENT
    MOLLER, HJ
    KISSLING, W
    VONZERSSEN, D
    PHARMACOPSYCHIATRIA, 1983, 16 (02): : 46 - 49
  • [25] ENDOCRINE RESPONSES TO TRYPTOPHAN INFUSION IN SCHIZOPHRENIC-PATIENTS TREATED WITH NEUROLEPTICS
    KOLAKOWSKA, T
    COWEN, PJ
    MURDOCK, P
    PSYCHONEUROENDOCRINOLOGY, 1987, 12 (03) : 193 - 202
  • [26] Quality of life and treatment costs in schizophrenic outpatients, treated with depot neuroleptics
    Demovsek, MZ
    Rupel, VP
    Rebolj, M
    Tavcar, R
    EUROPEAN PSYCHIATRY, 2001, 16 (08) : 474 - 482
  • [27] THE BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL AND DEPOT INTRAMUSCULAR HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS
    NAYAK, RK
    DOOSE, DR
    NAIR, NPV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (02): : 144 - 150
  • [28] PSYCHOTHERAPY IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS
    MORRISON, NK
    AMERICAN JOURNAL OF PSYCHIATRY, 1986, 143 (11): : 1489 - 1490
  • [29] Atypical neuroleptics in the treatment of schizophrenic patients
    Finzen, A
    PSYCHIATRISCHE PRAXIS, 2002, 29 (02) : 100 - 100
  • [30] DOGMATIL FOR THE TREATMENT OF SCHIZOPHRENIC-PATIENTS
    WIESEL, FA
    BJERKENSTEDT, L
    HARNRYD, C
    OXENSTIERNA, G
    SEDVALL, G
    SEMAINE DES HOPITAUX, 1985, 61 (19): : 1343 - 1346